The ZEUS System by iRhythm Technologies is a software platform designed to analyze ECG data from wearable cardiac monitors to detect arrhythmias and other heart rhythm abnormalities. It uses AI algorithms to automatically process and identify cardiac events, assisting clinicians in diagnosing and managing heart conditions by generating detailed reports from long-term ECG recordings.
The device is intended to capture, analyze and report symptomatic and asymptomatic cardiac events and continuous electrocardiogram information for long-term monitoring in patients 18 years or older.
The system is software-based, utilizing AI algorithms including an AutoTrigger Engine and ECGDL software to analyze ECG data from wearable monitors, automatically detecting arrhythmias and cardiac rhythms, with results reviewed by technicians before report generation.
The device underwent design verification and validation testing demonstrating conformance with FDA-recognized standards for risk management, software lifecycle, and ambulatory ECG safety and performance, confirming substantial equivalence to predicate devices without new safety or efficacy concerns.
No predicate devices specified
Submission
8/8/2022
FDA Approval
2/15/2023
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.